3-38598927-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The NM_001099404.2(SCN5A):c.2014G>A(p.Ala672Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000393 in 1,613,816 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001099404.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.2014G>A | p.Ala672Thr | missense_variant | 13/28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.2014G>A | p.Ala672Thr | missense_variant | 13/28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.2014G>A | p.Ala672Thr | missense_variant | 13/28 | 5 | NM_001099404.2 | ENSP00000410257 | P4 | |
SCN5A | ENST00000423572.7 | c.2014G>A | p.Ala672Thr | missense_variant | 13/28 | 1 | NM_000335.5 | ENSP00000398266 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000795 AC: 198AN: 248926Hom.: 1 AF XY: 0.00110 AC XY: 149AN XY: 134956
GnomAD4 exome AF: 0.000410 AC: 599AN: 1461534Hom.: 9 Cov.: 31 AF XY: 0.000630 AC XY: 458AN XY: 727042
GnomAD4 genome AF: 0.000236 AC: 36AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74442
ClinVar
Submissions by phenotype
not provided Benign:3Other:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 22, 2017 | Variant summary: The SCN5A c.2014G>A (p.Ala672Thr) variant involves the alteration of a conserved nucleotide. 2/3 in silico tools predict a benign outcome for this variant (SNPsandGO and MutationTaster not captured due to low reliability index). This variant was found in 111/140944 control chromosomes (1 homozygote), predominantly observed in the South Asian subpopulation at a frequency of 0.005815 (96/16510). This frequency is about 58 times the estimated maximal expected allele frequency of a pathogenic SCN5A variant (0.0001), suggesting this is likely a benign polymorphism found primarily in the populations of South Asian origin. The variant has been reported in the literature, mostly in controls, and without strong evidence for causality. In addition, one clinical diagnostic laboratory has classified this variant as likely benign. Taken together, this variant is classified as likely benign. - |
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported in the following publications (PMID:19841300;PMID:20129283). - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 08, 2019 | This variant is associated with the following publications: (PMID: 20129283, 19841300, 25351510) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | - - |
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Apr 14, 2011 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. p.Ala672Thr (A672T; c.2014 G>A) in the SCN5A gene This variant has not previously been reported in any individuals with LQTS or Brugada syndrome. It has, however, been seen in controls of 3 different ancestries. In total this variant has been seen in 3 out of ~8800 individuals from published controls and publicly available population datasets. In terms of Caucasian controls ethnically-matched to our patient, it has been seen in 1 out of ~5328 individuals. Kapa et al. from Ackerman’s group (2009; also Kapplinger et al. 2010) found the variant in 1 control individual of Asian ancestry out of ~1300 mixed-race controls (649 of which were Caucasian). This same paper reports that 3% of controls were positive for a variant in SCN5A. This variant is also present in 1 European American individual in the NHLBI Exome Sequencing Project dataset, which currently includes variant calls on ~4300 Caucasian and ~2200 African American individuals (as of 1/7/2013). It is present in dbSNP as rs199473140, and the source of this is 1 individual of Mexican ancestry in 1000 Genomes. (1000 Genomes contains 1092 individuals, 379 of which are of European ancestry.) GeneDx did not report controls. Variation at a nearby residues (plus or minus 10 amino acids) has been associated with disease, suggesting the possible functional importance of this region of the protein: L673P (LQT3) is in HGMD according to GeneDx; other variants include R680H (associated with SIDS; also with increased sodium current in vitro, but only under conditions of internal acidosis) and H681P (Brugada) (UniProtKB; IRCCS Fondazione Salvatore Maugeri database, citing Arnestad et al. 2007 and Priori et al. 2002). This is a non-conservative amino acid change, resulting in the replacement of a nonpolar, hydrophobic alanine with a polar, hydrophilic threonine. The alanine at this location is not highly conserved among vertebrates; in fact, the reference amino acid is a threonine in 6 species of fish. In silico analysis with PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/) predicts the variant to be “benign” with a score of 0.005. SIFT predicts it to be “tolerated” with a score of 1. - |
Primary dilated cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Genetics and Genomics Program, Sidra Medicine | - | - - |
SCN5A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 09, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Cardiac arrhythmia Benign:1
Benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | May 29, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at